{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:29:35Z","timestamp":1789896575671,"version":"4.0.1"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["seminperinat.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Perinatology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1053\/j.semperi.2014.03.002","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T11:24:50Z","timestamp":1400153090000},"page":"177-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Prediction and prevention of ischemic placental disease"],"prefix":"10.1053","volume":"38","author":[{"given":"Alexander M.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten L.","family":"Cleary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejogrb.2011.07.025","article-title":"Ischemic placental disease: epidemiology and risk factors","volume":"159","author":"Ananth","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clp.2007.11.001","article-title":"Medically indicated preterm birth: recognizing the importance of the problem","volume":"35","author":"Ananth","year":"2008","journal-title":"Clin Perinatol"},{"key":"10.1053\/j.semperi.2014.03.002_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000406845","article-title":"Morphologic changes in the hypertensive placenta","volume":"9","author":"Soma","year":"1982","journal-title":"Contrib Gynecol Obstet"},{"issue":"4","key":"10.1053\/j.semperi.2014.03.002_bib4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00003081-199712000-00008","article-title":"Placental pathology of fetal growth restriction","volume":"40","author":"Salafia","year":"1997","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0143-4004(80)80016-6","article-title":"An ultrastructural and ultrahistochemical study of the human placenta in maternal pre-eclampsia","volume":"1","author":"Jones","year":"1980","journal-title":"Placenta"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib6","doi-asserted-by":"crossref","first-page":"273e271","DOI":"10.1016\/j.ajog.2007.05.047","article-title":"Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease?","volume":"197","author":"Ananth","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.AOG.0000266983.77458.71","article-title":"Recurrence of ischemic placental disease","volume":"110","author":"Ananth","year":"2007","journal-title":"Obstet Gynecol"},{"issue":"8898","key":"10.1053\/j.semperi.2014.03.002_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0140-6736(94)92633-6","article-title":"CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women","volume":"343","year":"1994","journal-title":"Lancet"},{"issue":"17","key":"10.1053\/j.semperi.2014.03.002_bib9","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM199310213291701","article-title":"Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"329","author":"Sibai","year":"1993","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.semperi.2014.03.002_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198908103210604","article-title":"Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension","volume":"321","author":"Benigni","year":"1989","journal-title":"N Engl J Med"},{"issue":"8433","key":"10.1053\/j.semperi.2014.03.002_bib11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S0140-6736(85)92207-X","article-title":"Prevention of pre-eclampsia by early antiplatelet therapy","volume":"1","author":"Beaufils","year":"1985","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.semperi.2014.03.002_bib12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM198908103210603","article-title":"The use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies","volume":"321","author":"Schiff","year":"1989","journal-title":"N Engl J Med"},{"issue":"8471","key":"10.1053\/j.semperi.2014.03.002_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(86)91891-X","article-title":"Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae","volume":"1","author":"Wallenburg","year":"1986","journal-title":"Lancet"},{"issue":"8842","key":"10.1053\/j.semperi.2014.03.002_bib14","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0140-6736(93)92988-6","article-title":"Low-dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy-induced hypertension. Italian study of aspirin in pregnancy","volume":"341","year":"1993","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","article-title":"ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women","volume":"103","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"issue":"11","key":"10.1053\/j.semperi.2014.03.002_bib16","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1471-0528.1998.tb10089.x","article-title":"A randomised trial of low dose aspirin for primiparae in pregnancy. The Jamaica Low Dose Aspirin Study Group","volume":"105","author":"Golding","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib18","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1471-0528.1998.tb10088.x","article-title":"Barbados Low Dose Aspirin Study in Pregnancy (BLASP): a randomised trial for the prevention of pre-eclampsia and its complications","volume":"105","author":"Rotchell","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.03.002_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1471-0528.2003.t01-1-02097.x","article-title":"Aspirin (100mg) used for prevention of pre-eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1)","volume":"110","author":"Subtil","year":"2003","journal-title":"BJOG"},{"issue":"10","key":"10.1053\/j.semperi.2014.03.002_bib20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1001\/jama.1990.03440100097014","article-title":"The existence of publication bias and risk factors for its occurrence","volume":"263","author":"Dickersin","year":"1990","journal-title":"J Am Med Assoc"},{"issue":"8898","key":"10.1053\/j.semperi.2014.03.002_bib21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0140-6736(94)92630-1","article-title":"CLASP: millstone or milestone?","volume":"343","author":"Darling","year":"1994","journal-title":"Lancet"},{"issue":"5","key":"10.1053\/j.semperi.2014.03.002_bib22","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/uog.12470","article-title":"Aspirin for pre-eclampsia: beware of subgroup meta-analysis","volume":"41","author":"Meher","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"9575","key":"10.1053\/j.semperi.2014.03.002_bib23","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/S0140-6736(07)60712-0","article-title":"Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data","volume":"369","author":"Askie","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1053\/j.semperi.2014.03.002_bib24","first-page":"CD004659","article-title":"Antiplatelet agents for preventing pre-eclampsia and its complications","author":"Duley","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"2 Pt 1","key":"10.1053\/j.semperi.2014.03.002_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.03.002_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/uog.12421","article-title":"Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis","volume":"41","author":"Roberge","year":"2013","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib27","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1471-0528.2012.03493.x","article-title":"Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials","volume":"120","author":"Villa","year":"2013","journal-title":"BJOG"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1053\/j.ackd.2013.01.001","article-title":"Emerging new biomarkers of preeclampsia","volume":"20","author":"Polsani","year":"2013","journal-title":"Adv Chronic Kidney Dis"},{"issue":"6","key":"10.1053\/j.semperi.2014.03.002_bib29","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/AOG.0b013e3182571669","article-title":"First-trimester prediction of preeclampsia in nulliparous women at low risk","volume":"119","author":"Myatt","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2014.03.002_bib30","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0002-9378(88)90091-9","article-title":"The relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidence","volume":"158","author":"Belizan","year":"1988","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1053\/j.semperi.2014.03.002_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199707103370201","article-title":"Trial of calcium to prevent preeclampsia","volume":"337","author":"Levine","year":"1997","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.ajog.2006.01.068","article-title":"World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women","volume":"194","author":"Villar","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"10.1053\/j.semperi.2014.03.002_bib33","first-page":"CD001059","article-title":"Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems","author":"Hofmeyr","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1053\/j.semperi.2014.03.002_bib34","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3109\/14767058.2012.715220","article-title":"Calcium supplementation and prevention of preeclampsia: a meta-analysis","volume":"25","author":"Patrelli","year":"2012","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9517","key":"10.1053\/j.semperi.2014.03.002_bib35","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(06)68433-X","article-title":"Vitamins in Pre-eclampsia Trial C. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial","volume":"367","author":"Poston","year":"2006","journal-title":"Lancet"},{"issue":"6","key":"10.1053\/j.semperi.2014.03.002_bib36","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1471-0528.2009.02158.x","article-title":"World Health Organisation multicentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries","volume":"116","author":"Villar","year":"2009","journal-title":"BJOG"},{"issue":"17","key":"10.1053\/j.semperi.2014.03.002_bib37","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa054186","article-title":"Vitamins C and E and the risks of preeclampsia and perinatal complications","volume":"354","author":"Rumbold","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1053\/j.semperi.2014.03.002_bib38","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJMoa0908056","article-title":"Vitamins C and E to prevent complications of pregnancy-associated hypertension","volume":"362","author":"Roberts","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.semperi.2014.03.002_bib39","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/oxfordjournals.epirev.a036127","article-title":"Consumption of marine n-3 fatty acids during pregnancy as a possible determinant of birth weight. A review of the current epidemiologic evidence","volume":"15","author":"Olsen","year":"1993","journal-title":"Epidemiol Rev"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib40","first-page":"CD003402","article-title":"Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction","author":"Makrides","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib41","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1471-0528.2000.tb13235.x","article-title":"Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team","volume":"107","author":"Olsen","year":"2000","journal-title":"BJOG"},{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib42","first-page":"CD004227","article-title":"Antioxidants for preventing pre-eclampsia","author":"Rumbold","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.semperi.2014.03.002_bib43","first-page":"CD006780","article-title":"Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction","volume":"7","author":"Dodd","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1053\/j.semperi.2014.03.002_bib44","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/plac.1999.0417","article-title":"Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, pre-eclampsia and spontaneous pregnancy loss: a systematic review","volume":"20","author":"Ray","year":"1999","journal-title":"Placenta"},{"issue":"2","key":"10.1053\/j.semperi.2014.03.002_bib45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00439-008-0531-7","article-title":"Reduced folate carrier 80A\u2013>G polymorphism, plasma folate, and risk of placental abruption","volume":"124","author":"Ananth","year":"2008","journal-title":"Hum Genet"},{"issue":"7","key":"10.1053\/j.semperi.2014.03.002_bib46","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/aje\/kwm373","article-title":"Folic acid and multivitamin supplement use and risk of placental abruption: a population-based registry study","volume":"167","author":"Nilsen","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1053\/j.semperi.2014.03.002_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/aje\/kwm073","article-title":"Influence of maternal smoking on placental abruption in successive pregnancies: a population-based prospective cohort study in Sweden","volume":"166","author":"Ananth","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1053\/j.semperi.2014.03.002_bib48","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/01.AOG.0000239439.04364.9a","article-title":"Placental abruption","volume":"108","author":"Oyelese","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"2 Pt 1","key":"10.1053\/j.semperi.2014.03.002_bib49","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/AOG.0b013e31827d8ad5","article-title":"Pravastatin for the prevention of preeclampsia in high-risk pregnant women","volume":"121","author":"Costantine","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1053\/j.semperi.2014.03.002_bib50","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/HYPERTENSIONAHA.111.00226","article-title":"Pravastatin attenuates hypertension, oxidative stress, and angiogenic imbalance in rat model of placental ischemia-induced hypertension","volume":"61","author":"Bauer","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"10.1053\/j.semperi.2014.03.002_bib51","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/AOG.0b013e3181e10ebd","article-title":"Using pravastatin to improve the vascular reactivity in a mouse model of soluble fms-like tyrosine kinase-1-induced preeclampsia","volume":"116","author":"Costantine","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1053\/j.semperi.2014.03.002_bib52","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1073\/pnas.1011293108","article-title":"Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model","volume":"108","author":"Kumasawa","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1053\/j.semperi.2014.03.002_bib53","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/ajmg.a.32493","article-title":"Maternal exposure to statins and risk for birth defects: a case-series approach","volume":"146A","author":"Petersen","year":"2008","journal-title":"Am J Med Genetics. Part A"},{"issue":"8","key":"10.1053\/j.semperi.2014.03.002_bib54","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/1471-0528.12215","article-title":"Pre-eclampsia and cardiovascular disease: more questions than answers?","volume":"120","author":"Ananth","year":"2013","journal-title":"BJOG"},{"issue":"5","key":"10.1053\/j.semperi.2014.03.002_bib55","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1097\/01.AOG.0000437382.03963.88","article-title":"Task Force on Hypertension in Pregnancy. Hypertension in pregnancy: executive summary","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1053\/j.semperi.2014.03.002_bib56","doi-asserted-by":"crossref","first-page":"c2207","DOI":"10.1136\/bmj.c2207","article-title":"Management of hypertensive disorders during pregnancy: summary of NICE guidance","volume":"341","author":"Visintin","year":"2010","journal-title":"Br Med J"},{"issue":"suppl 2","key":"10.1053\/j.semperi.2014.03.002_bib57","doi-asserted-by":"crossref","first-page":"e691S","DOI":"10.1378\/chest.11-2300","article-title":"VTE, thrombophilia, antithrombotic therapy, and pregnancy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"}],"container-title":["Seminars in Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146000514000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T17:55:57Z","timestamp":1716746157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146000514000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0146000514000123"],"URL":"https:\/\/doi.org\/10.1053\/j.semperi.2014.03.002","relation":{},"ISSN":["0146-0005"],"issn-type":[{"value":"0146-0005","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction and prevention of ischemic placental disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Perinatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semperi.2014.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}